KRAS and gallbladder carcinoma: In patients, KRAS mutations were detected more frequently in pCCA (40%, 4/10) and dCCA (44.4%, 4/9) than in iCCA (5.9%, 2/34), while none was found in the gallbladder carcinoma specimens (0%, 0/8).